DC-Derived Exosomes for Cancer Immunotherapy

SIMPLE SUMMARY: Dendritic cells (DCs)-based cancer vaccines have not succeeded in generating significant clinical responses despite their capacity to induce host anti-tumor CD8 T cell immunity, and one major hurdle is tumor-mediated immunosuppression. Exosomes are nano-sized inert membrane vesicles...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Yi, Fu, Chunmei, Zhou, Li, Mi, Qing-Sheng, Jiang, Aimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345209/
https://www.ncbi.nlm.nih.gov/pubmed/34359569
http://dx.doi.org/10.3390/cancers13153667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345209/
https://www.ncbi.nlm.nih.gov/pubmed/34359569
http://dx.doi.org/10.3390/cancers13153667

Ejemplares similares